Journal-News: UC studies art, pet robot therapy
University of Cincinnati researchers are studying how art therapy delivered through a mobile app and pet therapy with a robotic dog can affect the wellbeing and mental health of patients with hearing loss.
All patients in the pilot study will be given a tablet, create art based on prompts from the app and then self-report on their mood. Half of the patients in the study will additionally be given a robotic dog to interact with.
Claudia B. Rebola, PhD, associate dean for research, associate professor and director of the new Center for DAAP Research and Innovation (CDRI) on Health and Wellbeing in the University of Cincinnati's College of Design, Architecture, Art, and Planning, told the Journal-News that patients can quickly develop attachments to the robotic dogs like they do with real furry friends.
“And while you know it’s an animal robotic agent — it’s not a real dog — you attach feelings to it, in terms of routines, and interactions, and you expect a bark in response to, let’s say I turn on the lights, and then the dog barks, like saying, ‘hello.’ So you quickly develop a sense of presence with these robots in your life," she said.
Read the Journal-News article. (Note: Article may require a subscription.)
Featured photo at top of robotic dog. Photo/Ravenna Rutledge/University of Cincinnati.
Related Stories
UC Cancer Center taps new director
February 11, 2026
The Cincinnati Business Courier spoke with David Gius, MD, PhD, who was recently named the next director of the University of Cincinnati Cancer Center.
UC researcher adds Chicago collaboration
February 11, 2026
University of Cincinnati research examining how public art and murals influence foot traffic, neighborhood vitality and economic development is now shaping planning conversations well beyond Cincinnati.
UC trial tests new nonpharmacological treatments for depression
February 11, 2026
The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.